BACKGROUND AND OBJECTIVES: Transplant options for type I diabetics with end-stage renal disease include simultaneous pancreas-kidney (SPKT), living donor kidney (LDKT), and deceased donor kidney transplant (DDKT). It is unclear whether SPKT offers a survival benefit over LDKT in the current era of transplantation. The authors compared outcomes of kidney transplant recipients with type I diabetes using data from the Organ Procurement and Transplant Network/United Network for Organ Sharing. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Adult (age 20 to 59) type I diabetics who received a solitary first-time kidney transplant between 2000 and 2007 were studied. Outcomes included overall kidney graft and patient survival. Multivariate analysis was performed using a stepwise Cox proportional hazards model. RESULTS: Kidney graft survival was better for recipients of LDKT compared with SPKT (P = 0.008), although patient survival was similar (P = 0.346). On multivariate analysis, LDKT was associated with lower adjusted risks over 72 mo follow-up of kidney graft failure (HR 0.71; 95% CI 0.61 to 0.83) and patient death (HR 0.78; 95% CI 0.65 to 0.94) versus SPKT. Compared with DDKT, SPKT had superior unadjusted kidney graft and patient survival, partly due to favorable SPKT donor and recipient factors. CONCLUSIONS: Despite more transplants from older donors and among older recipients, LDKT was associated with superior outcomes compared with SPKT and was coupled with the least wait time and dialysis exposure. LDKT utilization should be considered in all type I diabetics with an available living donor, particularly given the challenges of ongoing organ shortage.
BACKGROUND AND OBJECTIVES: Transplant options for type I diabetics with end-stage renal disease include simultaneous pancreas-kidney (SPKT), living donor kidney (LDKT), and deceased donor kidney transplant (DDKT). It is unclear whether SPKT offers a survival benefit over LDKT in the current era of transplantation. The authors compared outcomes of kidney transplant recipients with type I diabetes using data from the Organ Procurement and Transplant Network/United Network for Organ Sharing. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Adult (age 20 to 59) type I diabetics who received a solitary first-time kidney transplant between 2000 and 2007 were studied. Outcomes included overall kidney graft and patient survival. Multivariate analysis was performed using a stepwise Cox proportional hazards model. RESULTS: Kidney graft survival was better for recipients of LDKT compared with SPKT (P = 0.008), although patient survival was similar (P = 0.346). On multivariate analysis, LDKT was associated with lower adjusted risks over 72 mo follow-up of kidney graft failure (HR 0.71; 95% CI 0.61 to 0.83) and patient death (HR 0.78; 95% CI 0.65 to 0.94) versus SPKT. Compared with DDKT, SPKT had superior unadjusted kidney graft and patient survival, partly due to favorable SPKT donor and recipient factors. CONCLUSIONS: Despite more transplants from older donors and among older recipients, LDKT was associated with superior outcomes compared with SPKT and was coupled with the least wait time and dialysis exposure. LDKT utilization should be considered in all type I diabetics with an available living donor, particularly given the challenges of ongoing organ shortage.
Authors: Bryan N Becker; Jon S Odorico; Yolanda T Becker; Marilyn Groshek; Cathy Werwinski; John D Pirsch; Hans W Sollinger Journal: J Am Soc Nephrol Date: 2001-11 Impact factor: 10.121
Authors: Sundaram Hariharan; John D Pirsch; Christopher Y Lu; Laurence Chan; Todd E Pesavento; Steven Alexander; Ginny L Bumgardner; Giacomo Baasadona; Donald E Hricik; Mark D Pescovitz; Nina T Rubin; Robert J Stratta Journal: J Am Soc Nephrol Date: 2002-04 Impact factor: 10.121
Authors: R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port Journal: N Engl J Med Date: 1999-12-02 Impact factor: 91.245
Authors: Herwig-Ulf Meier-Kriesche; Akinlolu O Ojo; Friedrich K Port; Julie A Arndorfer; Diane M Cibrik; Bruce Kaplan Journal: J Am Soc Nephrol Date: 2001-06 Impact factor: 10.121
Authors: A O Ojo; H U Meier-Kriesche; J A Hanson; A Leichtman; J C Magee; D Cibrik; R A Wolfe; F K Port; L Agodoa; D B Kaufman; B Kaplan Journal: Transplantation Date: 2001-01-15 Impact factor: 4.939
Authors: Kalathil K Sureshkumar; Tariq Mubin; Nabil Mikhael; Mohammed Ahmer Kashif; Dai D Nghiem; Richard J Marcus Journal: Am J Kidney Dis Date: 2002-06 Impact factor: 8.860
Authors: Y Mun Woo; Douglas McLean; David Kavanagh; Lucie Ward; Stuart Aitken; Graham J Miller; Patricia Egan; Katherine Hughes; Louise Clark; Kirstin Carswell; Scott T W Morris; David B Northridge; R Stuart Rodger; Alan G Jardine Journal: J Nephrol Date: 2002 Jul-Aug Impact factor: 3.902
Authors: S C Rayhill; A M D'Alessandro; J S Odorico; S J Knechtle; J D Pirsch; D M Heisey; A D Kirk; W Van der Werf; H W Sollinger Journal: Ann Surg Date: 2000-03 Impact factor: 12.969
Authors: Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski Journal: Transplantation Date: 2016-02 Impact factor: 4.939
Authors: Jørn P Lindahl; Finn P Reinholt; Ivar A Eide; Anders Hartmann; Karsten Midtvedt; Hallvard Holdaas; Linda T Dorg; Trine M Reine; Svein O Kolset; Rune Horneland; Ole Øyen; Knut Brabrand; Trond Jenssen Journal: Diabetologia Date: 2014-08-22 Impact factor: 10.122
Authors: J P Lindahl; A Hartmann; R Horneland; H Holdaas; A V Reisæter; K Midtvedt; T Leivestad; O Oyen; T Jenssen Journal: Diabetologia Date: 2013-04-03 Impact factor: 10.122